Horacio Padua
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Horacio Padua has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Raja Shaikh
Department of Radiology, Boston Children's Hospital, Boston, Massachusetts
5 shared publications - Gulraiz Chaudry
Boston Children's Hospital
4 shared publications - Mohammad Amarneh
Division of Vascular and Interventional Radiology, Boston Children’s Hospital, Harvard Medical School, Boston, USA
4 shared publications - Ahmad Ibrahim Alomari
Division of Vascular and Interventional Radiology, Boston Children's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts
3 shared publications Raja Shaikh
3 shared publications- Kyung Rae Kim
School of Medicine, University of North Carolina, Chapel Hill, NC, United States
2 shared publications
Latest Publications
- 14 October 2025
- Published by Cassyni
Angioplasty for Renal Artery Stenosis in Children
## Introduction Renal artery stenosis (RAS) is a rare but important cause of hypertension in children patients. Percutaneous renal angioplasty (PTRA) offers a minimally invasive therapeutic option, but data on its efficacy in children remain limited, particularly if associated with mid-aortic stenosis. ## Materials and Methods This retrospective study included children with hypertension secondary to RAS who underwent PTRA at a tertiary care pediatric hospital. Data on patient characteristics, procedural details, and outcomes were collected. Clinical success was defined as improved blood pressure control or reduction in antihypertensive use. Technical success was categorized as complete (<25% residual stenosis) or partial (25–69% residual stenosis) resolution. Descriptive and subgroup analyses were performed. ## Results Fifteen patients (mean age 10.1 ± 4.2 years, 8 males) underwent 20 angioplasties. Five patients (33.3%) had mid-aortic syndrome (MAS). Most stenoses were right-sided (40%), with 26.7% bilateral. Hypertension was incidentally diagnosed in 73.3% of cases. Non-cutting balloons were used in 95% of procedures, and minor complications occurred in two cases (hematoma, intimal dissection). Clinical success was achieved in all procedures (100%), while technical success was complete in 60% and partial in 40%. Subgroup analysis showed no significant difference in outcomes between MAS-associated and isolated RAS. ## Discussion Percutaneous renal angioplasty is a safe and effective treatment for RAS in children, with high clinical success and acceptable technical outcomes.
- 14 October 2025
- Published by Cassyni
Angioplasty for Renal Artery Stenosis in Children
## Introduction Renal artery stenosis (RAS) is a rare but important cause of hypertension in children patients. Percutaneous renal angioplasty (PTRA) offers a minimally invasive therapeutic option, but data on its efficacy in children remain limited, particularly if associated with mid-aortic stenosis. ## Materials and Methods This retrospective study included children with hypertension secondary to RAS who underwent PTRA at a tertiary care pediatric hospital. Data on patient characteristics, procedural details, and outcomes were collected. Clinical success was defined as improved blood pressure control or reduction in antihypertensive use. Technical success was categorized as complete (<25% residual stenosis) or partial (25–69% residual stenosis) resolution. Descriptive and subgroup analyses were performed. ## Results Fifteen patients (mean age 10.1 ± 4.2 years, 8 males) underwent 20 angioplasties. Five patients (33.3%) had mid-aortic syndrome (MAS). Most stenoses were right-sided (40%), with 26.7% bilateral. Hypertension was incidentally diagnosed in 73.3% of cases. Non-cutting balloons were used in 95% of procedures, and minor complications occurred in two cases (hematoma, intimal dissection). Clinical success was achieved in all procedures (100%), while technical success was complete in 60% and partial in 40%. Subgroup analysis showed no significant difference in outcomes between MAS-associated and isolated RAS. ## Discussion Percutaneous renal angioplasty is a safe and effective treatment for RAS in children, with high clinical success and acceptable technical outcomes.
- Open Access
- 6 April 2025
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 11 (4) , 101796
Liposomal bupivacaine infiltration for postprocedural analgesia following interventional procedures for vascular anomalies
- 6 April 2025
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 11 (4) , 101796
Open AccessLiposomal bupivacaine infiltration for postprocedural analgesia following interventional procedures for vascular anomalies
- 15 March 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (6) , 1112-1117
Qualitative evaluation of magnetic resonance imaging features in aneurysmal bone cysts after percutaneous cryoablation
Background Aneurysmal bone cysts (ABCs) are benign vascular lesions commonly affecting the pediatric population. Objective To assess magnetic resonance imaging (MRI) features of ABCs after percutaneous cryoablation. Materials and methods A retrospective review of the hospital’s electronic medical record database was conducted to identify patients who underwent percutaneous image-guided cryoablation for aneurysmal bone cysts between March 2014 and April 2024. Patients were excluded if they lacked pre- or post-treatment MRI, underwent surgical curettage and bone grafting between cryoablation treatments, or received adjunctive therapies such as sclerotherapy or bone grafting. Demographic data and pre- and post-cryoablation MRI characteristics of the lesions were collected and analyzed. Results We retrospectively analyzed 20 patients (mean age = 14.6 years). The average ABC volume decreased from 83 cm3 pre-treatment to 32.7 cm3 post-treatment. In the final post-treatment MRI, there was a 50% decrease in the cystic component in 90% (n = 18) of patients, improved cortical integrity in 75% (n = 9), resolution of peri-lesional edema and mass effect in all (n = 20), and development of organized fibrosis in 50% (n = 10) of the patients. The average time was 8.3 months for a 50% reduction in cystic component, 7.3 months for improvement in cortical integrity, 6.4 months for improvement in mass effect, 15 months for complete resolution of peri-lesional enhancement, and 16.1 months for the development of organized fibrosis. Conclusion These findings suggest MRI is a valuable tool for monitoring ABC response to cryotherapy, guiding future treatment protocols. Graphical Abstract
- 15 March 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (6) , 1112-1117
Qualitative evaluation of magnetic resonance imaging features in aneurysmal bone cysts after percutaneous cryoablation
Background Aneurysmal bone cysts (ABCs) are benign vascular lesions commonly affecting the pediatric population. Objective To assess magnetic resonance imaging (MRI) features of ABCs after percutaneous cryoablation. Materials and methods A retrospective review of the hospital’s electronic medical record database was conducted to identify patients who underwent percutaneous image-guided cryoablation for aneurysmal bone cysts between March 2014 and April 2024. Patients were excluded if they lacked pre- or post-treatment MRI, underwent surgical curettage and bone grafting between cryoablation treatments, or received adjunctive therapies such as sclerotherapy or bone grafting. Demographic data and pre- and post-cryoablation MRI characteristics of the lesions were collected and analyzed. Results We retrospectively analyzed 20 patients (mean age = 14.6 years). The average ABC volume decreased from 83 cm3 pre-treatment to 32.7 cm3 post-treatment. In the final post-treatment MRI, there was a 50% decrease in the cystic component in 90% (n = 18) of patients, improved cortical integrity in 75% (n = 9), resolution of peri-lesional edema and mass effect in all (n = 20), and development of organized fibrosis in 50% (n = 10) of the patients. The average time was 8.3 months for a 50% reduction in cystic component, 7.3 months for improvement in cortical integrity, 6.4 months for improvement in mass effect, 15 months for complete resolution of peri-lesional enhancement, and 16.1 months for the development of organized fibrosis. Conclusion These findings suggest MRI is a valuable tool for monitoring ABC response to cryotherapy, guiding future treatment protocols. Graphical Abstract
- 1 January 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 310 (1) , e232128
Age-specific Dose Catalog for Diagnostic Fluoroscopy and Fluoroscopically Guided Interventional Procedures from a Pediatric Hospital
Background Fluoroscopy is an imaging modality associated with a wide range of dose levels, characterized using a variety of dose metrics, including effective dose. However, for clinical procedures, effective dose is a seldom-used and unregulated metric in the United States, and thus, it is not extensively studied in radiology despite potentially large clinical implications for patients, especially children and infants. Purpose To formulate and report a dose catalog across all diagnostic and interventional radiology (IR) fluoroscopy examination or procedure types at a specialized tertiary care pediatric hospital. Materials and Methods In this retrospective study, dose metrics taken from radiation dose structured reports of fluoroscopy between October 2014 and March 2023 were analyzed. The reports included fluoroscopy across 18 diagnostic examination types and 24 IR procedure types. The National Cancer Institute dosimetry system for Radiography and Fluoroscopy Monte Carlo software was used to estimate age-specific effective dose from dose-area product (DAP). The DAP-to-effective dose conversion factors were estimated per IR procedure type and diagnostic fluoroscopy examination type based on age. Results A total of 11 536 individual diagnostic fluoroscopy examinations (18 types) and 8017 individual IR procedures (24 types) were analyzed. Median effective dose values per diagnostic fluoroscopy examination type ranged from 0.0010 to 0.44 mSv (mean, 0.0808 mSv ± 0.0998 [SD]). Calculated DAP-to-effective dose conversion factors ranged from 0.04 to 2.48 mSv/Gy · cm2 (mean, 0.758 mSv/Gy · cm2 ± 0.614) across all diagnostic fluoroscopy examination types. Median effective dose values per IR procedure type ranged from 0.0007 to 3.90 mSv (mean, 0.6757 mSv ± 0.8989). Calculated DAP-to-effective dose conversion factors ranged from 0.001 to 0.87 mSv/Gy · cm2 (mean, 0.210 mSv/Gy · cm2 ± 0.235) across all IR procedure types. Conclusion A pediatric fluoroscopy dose catalog was created, including age-specific effective dose, using a repeatable robust method based on accurate clinical data. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Borrego and Balter in this issue.
- 1 January 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 310 (1) , e232128
Age-specific Dose Catalog for Diagnostic Fluoroscopy and Fluoroscopically Guided Interventional Procedures from a Pediatric Hospital
Background Fluoroscopy is an imaging modality associated with a wide range of dose levels, characterized using a variety of dose metrics, including effective dose. However, for clinical procedures, effective dose is a seldom-used and unregulated metric in the United States, and thus, it is not extensively studied in radiology despite potentially large clinical implications for patients, especially children and infants. Purpose To formulate and report a dose catalog across all diagnostic and interventional radiology (IR) fluoroscopy examination or procedure types at a specialized tertiary care pediatric hospital. Materials and Methods In this retrospective study, dose metrics taken from radiation dose structured reports of fluoroscopy between October 2014 and March 2023 were analyzed. The reports included fluoroscopy across 18 diagnostic examination types and 24 IR procedure types. The National Cancer Institute dosimetry system for Radiography and Fluoroscopy Monte Carlo software was used to estimate age-specific effective dose from dose-area product (DAP). The DAP-to-effective dose conversion factors were estimated per IR procedure type and diagnostic fluoroscopy examination type based on age. Results A total of 11 536 individual diagnostic fluoroscopy examinations (18 types) and 8017 individual IR procedures (24 types) were analyzed. Median effective dose values per diagnostic fluoroscopy examination type ranged from 0.0010 to 0.44 mSv (mean, 0.0808 mSv ± 0.0998 [SD]). Calculated DAP-to-effective dose conversion factors ranged from 0.04 to 2.48 mSv/Gy · cm2 (mean, 0.758 mSv/Gy · cm2 ± 0.614) across all diagnostic fluoroscopy examination types. Median effective dose values per IR procedure type ranged from 0.0007 to 3.90 mSv (mean, 0.6757 mSv ± 0.8989). Calculated DAP-to-effective dose conversion factors ranged from 0.001 to 0.87 mSv/Gy · cm2 (mean, 0.210 mSv/Gy · cm2 ± 0.235) across all IR procedure types. Conclusion A pediatric fluoroscopy dose catalog was created, including age-specific effective dose, using a repeatable robust method based on accurate clinical data. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Borrego and Balter in this issue.
- Open Access
- 1 June 2023
- Published by Wiley in Cancer Medicine
- Vol. 12 (12) , 13300-13308
A single‐institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors
Background: Pediatric interventional oncology (PIO) is a growing field intended to provide additional or alternative treatment options for pediatric patients with benign or malignant tumors. Large series of patients treated uniformly and subjected to rigorous endpoints for efficacy are not available.Methods: We designed a collaborative initiative to capture data from pediatric patients with benign and malignant tumors who underwent a therapeutic interventional radiology procedure. Modified Response Evaluation Criteria in Solid Tumors (mRECIST) was utilized as a measure of radiologic response and data were collected regarding improvement in pain and functional endpoints. Cumulative incidence of progressive disease was calculated using both the treated site and the patient as the analytic unit.Findings: Forty patients, 16 with malignant tumors and 24 with benign tumors, underwent a total of 88 procedures. Cryo- and radiofrequency ablation were the most frequently utilized techniques for both cohorts of patients. A complete or partial response, or prolonged disease stability, were achieved in approximately 40% of patients with malignant tumors and 60% of patients with benign tumors. No patients had progressive disease as their best response. Resolution of pain and improved mobility with return-to-baseline activity were demonstrated across patients from both cohorts. Only minor complications were experienced.Interpretation: Interventional radiology-guided interventions can serve as an alternative or complementary approach to the treatment of benign and malignant tumors in pediatric patients. Prospective, multi-institutional trials are required to adequately study utility, treatment endpoints, and durability of response.
- 1 June 2023
- Published by Wiley in Cancer Medicine
- Vol. 12 (12) , 13300-13308
Open AccessA single‐institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors
Background: Pediatric interventional oncology (PIO) is a growing field intended to provide additional or alternative treatment options for pediatric patients with benign or malignant tumors. Large series of patients treated uniformly and subjected to rigorous endpoints for efficacy are not available.Methods: We designed a collaborative initiative to capture data from pediatric patients with benign and malignant tumors who underwent a therapeutic interventional radiology procedure. Modified Response Evaluation Criteria in Solid Tumors (mRECIST) was utilized as a measure of radiologic response and data were collected regarding improvement in pain and functional endpoints. Cumulative incidence of progressive disease was calculated using both the treated site and the patient as the analytic unit.Findings: Forty patients, 16 with malignant tumors and 24 with benign tumors, underwent a total of 88 procedures. Cryo- and radiofrequency ablation were the most frequently utilized techniques for both cohorts of patients. A complete or partial response, or prolonged disease stability, were achieved in approximately 40% of patients with malignant tumors and 60% of patients with benign tumors. No patients had progressive disease as their best response. Resolution of pain and improved mobility with return-to-baseline activity were demonstrated across patients from both cohorts. Only minor complications were experienced.Interpretation: Interventional radiology-guided interventions can serve as an alternative or complementary approach to the treatment of benign and malignant tumors in pediatric patients. Prospective, multi-institutional trials are required to adequately study utility, treatment endpoints, and durability of response.
- Open Access
- 13 November 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (4) , 544-555.e11
Patient Radiation Doses in IR Procedures: The American College of Radiology Dose Index Registry-Fluoroscopy Pilot
- 13 November 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (4) , 544-555.e11
Open AccessPatient Radiation Doses in IR Procedures: The American College of Radiology Dose Index Registry-Fluoroscopy Pilot
- Open Access
- 1 November 2022
- Published by SAGE Publications in Journal of Children's Orthopaedics
- Vol. 16 (6) , 512-518
Bedside hip aspiration results in decrease in total general anesthesia time in pediatric patients: A multicenter study
Purpose: The purpose of this study is to compare pediatric hip aspiration in the operating room under general anesthesia or via bedside aspiration under moderate sedation and delineate the anesthetic time required. Methods: A database query conducted at two academic institutions identified all patients under the age of 17 who underwent hip aspiration between 2000 and 2017. At one institution, aspiration was performed in the operating room under general anesthesia. Patients were kept anesthetized until cell count was complete. At the second institution, aspiration was performed in the emergency room at bedside under sedation. The medical record was reviewed for demographic data, hip aspiration results, diagnoses, treatment, and anesthesia time. Results: A total of 233 patients (233 hips) with a mean age of 7.2 years were identified. Seventy-five patients underwent aspiration in the operating room, and 158 patients underwent bedside aspiration. Patients with a negative aspiration averaged 87 min under anesthesia when performed in the operating room and 29 min under sedation when performed at bedside. Patients with a negative aspiration performed in the operating room after 5 pm averaged 99 min under anesthesia, and 73 min under anesthesia when performed between 7 am and 5 pm (p < 0.01). Seventy-eight (49%) patients who underwent bedside aspiration did not require operative intervention and therefore avoided general anesthesia. Conclusion: Pediatric hip aspiration performed in the operating room results in prolonged anesthesia times while synovial fluid is transported and processed. Anesthesia times are significantly longer after 5 pm. Bedside aspiration resulted in significantly less anesthesia exposure, with half of patients undergoing bedside aspiration avoiding general anesthesia altogether. Level of evidence: Level III.
- 1 November 2022
- Published by SAGE Publications in Journal of Children's Orthopaedics
- Vol. 16 (6) , 512-518
Open AccessBedside hip aspiration results in decrease in total general anesthesia time in pediatric patients: A multicenter study
Purpose: The purpose of this study is to compare pediatric hip aspiration in the operating room under general anesthesia or via bedside aspiration under moderate sedation and delineate the anesthetic time required. Methods: A database query conducted at two academic institutions identified all patients under the age of 17 who underwent hip aspiration between 2000 and 2017. At one institution, aspiration was performed in the operating room under general anesthesia. Patients were kept anesthetized until cell count was complete. At the second institution, aspiration was performed in the emergency room at bedside under sedation. The medical record was reviewed for demographic data, hip aspiration results, diagnoses, treatment, and anesthesia time. Results: A total of 233 patients (233 hips) with a mean age of 7.2 years were identified. Seventy-five patients underwent aspiration in the operating room, and 158 patients underwent bedside aspiration. Patients with a negative aspiration averaged 87 min under anesthesia when performed in the operating room and 29 min under sedation when performed at bedside. Patients with a negative aspiration performed in the operating room after 5 pm averaged 99 min under anesthesia, and 73 min under anesthesia when performed between 7 am and 5 pm (p < 0.01). Seventy-eight (49%) patients who underwent bedside aspiration did not require operative intervention and therefore avoided general anesthesia. Conclusion: Pediatric hip aspiration performed in the operating room results in prolonged anesthesia times while synovial fluid is transported and processed. Anesthesia times are significantly longer after 5 pm. Bedside aspiration resulted in significantly less anesthesia exposure, with half of patients undergoing bedside aspiration avoiding general anesthesia altogether. Level of evidence: Level III.
- 13 July 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (11) , 1424-1431
Appendix to the Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions: Pediatric Considerations
- 13 July 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (11) , 1424-1431
Appendix to the Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions: Pediatric Considerations
- 12 July 2021
- Published by Springer Nature in Pediatric Radiology
- Vol. 51 (13) , 2588-2595
Intrathecal catheter and port placement for nusinersen infusion in children with spinal muscular atrophy and spinal fusion
Background Spinal administration of medications is challenging in patients with complete posterior spinal fusion. We describe percutaneous image-guided intrathecal port placement for administration of the antisense oligonucleotide nusinersen for children and young adults with spinal muscular atrophy. Objective To describe and present our initial experience with a new technique for administering nusinersen in patients with spinal muscular atrophy and posterior spinal fusion. Materials and methods We reviewed medical records of 13 patients who received intrathecal ports using DynaCT, biplane fluoroscopy and iGuide from April 2018 through June 2019, and we describe the clinical course over 1 year. Results Image-guided catheter and port implantation was successful in all cases. Two ports were subsequently removed, one for persistent cerebrospinal fluid leak and one for superficial infection. The other 11 have functioned successfully for a minimum of 23 months. Conclusion We report our experience with image-guided intrathecal port placement in children with complete posterior spine fusion. The implanted port permits dosing in an outpatient setting and avoids the need for multiple future radiologic procedures, and it reduces discomfort, procedural costs and potential risks and sequelae of multiple anesthetics and radiation exposures. Further studies are needed to define the relative risks and benefits of intrathecal ports compared to other approaches such as repeated transforaminal lumbar punctures.
- 12 July 2021
- Published by Springer Nature in Pediatric Radiology
- Vol. 51 (13) , 2588-2595
Intrathecal catheter and port placement for nusinersen infusion in children with spinal muscular atrophy and spinal fusion
Background Spinal administration of medications is challenging in patients with complete posterior spinal fusion. We describe percutaneous image-guided intrathecal port placement for administration of the antisense oligonucleotide nusinersen for children and young adults with spinal muscular atrophy. Objective To describe and present our initial experience with a new technique for administering nusinersen in patients with spinal muscular atrophy and posterior spinal fusion. Materials and methods We reviewed medical records of 13 patients who received intrathecal ports using DynaCT, biplane fluoroscopy and iGuide from April 2018 through June 2019, and we describe the clinical course over 1 year. Results Image-guided catheter and port implantation was successful in all cases. Two ports were subsequently removed, one for persistent cerebrospinal fluid leak and one for superficial infection. The other 11 have functioned successfully for a minimum of 23 months. Conclusion We report our experience with image-guided intrathecal port placement in children with complete posterior spine fusion. The implanted port permits dosing in an outpatient setting and avoids the need for multiple future radiologic procedures, and it reduces discomfort, procedural costs and potential risks and sequelae of multiple anesthetics and radiation exposures. Further studies are needed to define the relative risks and benefits of intrathecal ports compared to other approaches such as repeated transforaminal lumbar punctures.